Clinical Trials List
Protocol NumberYO45758
Active
2025-08-01 - 2030-12-31
Phase I
Recruiting2
ICD-10D49.9
Neoplasm of unspecified behavior of unspecified site
ICD-9239.9
Neoplasm of unspecified nature, site unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee 無
- 陳國興 無
- 廖唯昱 無
- James Chih-Hsin Yang 無
- 吳宗哲 無
- 廖斌志 無
- JIN-YUAN SHIH 無
- 許嘉林 無
- Kun-Huei Yeh 無
- 吳尚俊 無
- 蔡子修 無
- 楊景堯 無
- SHIH-HUNG YANG 無
- 梁逸歆 無
- YEN-TING LIN 無
- 徐偉勛 無
- CHAO-CHI HO CHAO-CHI HO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Peng-Chan Lin Division of Hematology & Oncology
- Po-Wen Lin Division of General Surgery
- 黃怡菁 Division of Hematology & Oncology
- 黃怡璇 無
- 劉奕廷 Division of Hematology & Oncology
- 鍾秉軒 Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- 黃盈慈 Division of Hematology & Oncology
- 陳柏全 Division of General Surgery
- Chun-Hui Lee Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
405 participants
